The brisk sales of injection molding machines driven by the medical needs of the pandemic and locked-down consumers shopping online started waning in 2022 and continue to slide.
Machine sales are down not only in comparison with the phenomenal years of 2021 and 2022 but also because high energy prices are reducing the appetite for investments, according to Gerhard Böhm, managing director of sales and after sales for Arburg GmbH + Co. K.G.
Capital expenditures have been limited to new projects starting up and essential capacity expansions, sending incoming orders into further decline.
"Currently, these are at a low level. Unfortunately, no clear, short-term improvement of the situation is in sight yet," Jürgen Boll, managing director of finance, controlling and IT, said during a news conference at Fakuma 2023.
Boll said the 100-year-old company generated "really magnificent" sales of 875 million euros ($932 million) in 2022, but this year he expects a decrease to 750 million euros ($800 million).
The Lossburg, Germany-based machine builder isn't alone.
"At the moment, we are facing a challenging situation due to the significant decline in incoming orders—like all other companies in the industry," Boll said.
Sales are down in Germany, where "people are always particularly cautious," and the rest of Europe except for Italy, Poland and Turkey, which are somewhat "better off" in comparison, Böhm said.